MedDataX Logo

Triceps Surae Ultrasonographic Characteristics in Hemiparetic Stroke Survivors

NCT ID: NCT05097482

Last Updated: 2021-10-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-14

Study Completion Date

2021-12-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate, in hemiparetic patients, changes in muscle ultrasound structure about the focal treatment of spasticity with botulinum toxin type A. For this purpose, the analysis of the mean echo intensity will be carried out on ultrasound acquisitions, identifying the possible correlations between the muscle echogenicity, the variations in the pennation angle, and the length of the fascicles.

For image processing operations, ImageJ software was applied.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spastic Foot Stroke

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

post-stroke spasticity muscle ultrasound

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* unilateral ischaemic or haemorrhagic stroke (documented with clinical examination and neuroradiological findings)
* presence of spasticity at lower limb muscles, at least grade 1+ in the modified Ashworth Scale 3.
* age ≥ 18 years

Exclusion Criteria

* inability to walk before stroke
* presence of severe cognitive impairment
* presence of other musculoskeletal, neurological or cardiopulmonary impairment which can interfere with clinical findings
* presence of skin lesions that can contraindicate BoNT-A treatment
* previous surgical myotendinous elongation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alessio Baricich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alessio Baricich

Professor in Physical and Rehabilitation Medicine

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maggiore della Carità University Hospital

Novara, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alessio Baricich, MD PhD

Role: CONTACT

Phone: 03213734844

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alessio Baricich

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TriUS

Identifier Type: -

Identifier Source: org_study_id